Trump's zambia blackmail: trading aids relief for mineral rights?
The Trump administration’s legacy isn’t just defined by golf courses and Twitter storms; it’s also etched in the faces of those whose lives were jeopardized by callous policy decisions. A newly surfaced memo, obtained by The New York Times, reveals a disturbing episode in Zambia: the attempted weaponization of critical HIV/AIDS relief funding to gain access to the country’s vast mineral wealth. It's a power play that echoes the ruthless maneuvering of a bygone era, and the consequences are tragically real.

A life-saving program undermined
For years, the George W. Bush-era PEPFAR program represented a rare and genuinely transformative achievement in global health. It provided hundreds of thousands of Zambians with access to life-saving antiretroviral medications, built a robust network of clinics and laboratories, and dramatically reduced the rate of new HIV infections. Life expectancy began to climb. But under the Trump administration, this progress was systematically dismantled. Funding was abruptly cut, then restored, then withheld again—a chaotic and destabilizing cycle that left the Zambian healthcare system reeling.
The heart of the matter lies in a recent demand: Zambia must accept a new health funding agreement tied to granting the United States expanded access to its mineral resources, including crucial components for the green energy transition like lithium and cobalt. The memo from the State Department's Africa Bureau, reads like a thinly veiled threat: “We will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale.” It’s not negotiation; it’s extortion.
The impact has been devastating. USAID programs, once reaching the regions with the highest rates of HIV prevalence, have shuttered. Index testing, a crucial method for identifying and treating new infections, has ground to a halt. Even routine services like reminding patients to take their medications—a task performed by community health workers—have largely disappeared. Consider this: 100,000 Zambians stopped taking their medication during this upheaval, and 40,000 have yet to be re-engaged. The consequences are far-reaching, with health officials bracing for a resurgence of infection rates.
What’s particularly galling is the regression to practices abandoned decades ago. Babies now face delayed HIV testing, data is tracked on paper instead of electronically, and vulnerable populations—gay men, sex workers—no longer have access to dedicated, safe service providers. It's a jarring return to the dark days of the AIDS epidemic, a period when the scale of the crisis remained tragically unclear.
The administration's actions demonstrate a profound disregard for human suffering, prioritizing short-term economic gain over the well-being of an entire nation. It’s a stark reminder that, sometimes, the most profound failures aren’t about what’s built, but what's carelessly destroyed.
As of today, 1.3 million Zambians remain on HIV treatment, a testament to the resilience of the nation's healthcare workers. But the fight is far from over, and the shadow of Washington’s indifference looms large.